Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on DC STEM Digest.
Press releases published on April 14, 2025
The BOW Collective is Set to Soar as Member Aisha Bowe Carries Flag Into Space Aboard Blue Origin's NS-31 Mission
EIN Presswire
·
April 14, 2025
WASHINGTON DC, DC, UNITED STATES, April 14, 2025 /EINPresswire.com/ -- The BOW Collective is thrilled to mark a groundbreaking moment in history as one of its own, aerospace engineer and entrepreneur Aisha Bowe, prepares to launch into space on Blue …
USEA To Hold Virtual Press Briefing on Electric Utilities in the Trump Tumult
EIN Presswire
·
April 14, 2025
The United States Energy Association will hold a live press briefing on Zoom, another in its energy series, on Wednesday, April 16 at 11 a.m. EDT. WASHINGTON, DC, UNITED STATES, April 14, 2025 /EINPresswire.com/ -- The tumult produced by President Trump …
STRmix Launches New Version of Investigative App for Calculating Likelihood Ratios
EIN Presswire
·
April 14, 2025
DBLR™ v1.5 Enables Use of Variable Number of Contributor Inputs, Updates to Reporting WASHINGTON, DC, UNITED STATES, April 14, 2025 /EINPresswire.com/ -- The team that created ground-breaking forensic software STRmix™ has launched DBLR™ v1.5, the …
.ART ANNOUNCES 2024 AND 2025 KASIMOV ART THERAPY FELLOWSHIP RECIPIENTS
EIN Presswire
·
April 14, 2025
WASHINGTON, DC, DC, UNITED STATES, April 14, 2025 /EINPresswire.com/ -- In celebration of the upcoming World Art Day, .ART Registry is proud to announce the 2025 recipients of the Kasimov Art Therapy Fellowship—an award established to support the next …
NAYA Biosciences Announces Strategic Decision to Separate Fertility and Oncology Businesses into Distinct Operations – Company Renamed “INVO Fertility, Inc.”
GlobeNewswire
·
April 14, 2025
Public company to operate under new name and concentrate on building, acquiring and operating fertility clinics and the distribution of FDA-cleared INVOcell device Private company to operate as NAYA Therapeutics and focus on clinical development of …
MediciNova To Participate in D. Boral’s Capital Global Conference on May 14, 2025
GlobeNewswire
·
April 14, 2025
LA JOLLA, Calif., April 14, 2025 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ: MNOV) and the Standard Market of the Tokyo Stock Exchange (Code Number: 4875), today announces that their CEO, …
Topicus.com Inc. Announces Release Date for First Quarter Results
GlobeNewswire
·
April 14, 2025
TORONTO, April 14, 2025 (GLOBE NEWSWIRE) -- Topicus.com Inc. (TSXV:TOI) announced today it intends to release its first quarter results on May 2, 2025. The Company’s quarterly results will be disseminated via press release and made available on the Company …
Constellation Software Inc. Announces Release Date for First Quarter Results
GlobeNewswire
·
April 14, 2025
TORONTO, April 14, 2025 (GLOBE NEWSWIRE) -- Constellation Software Inc. (TSX:CSU) announced today it intends to release its first quarter results on May 12, 2025. The Company’s quarterly results will be disseminated via press release and made available on …
HP Inc. Announces Pricing of Senior Notes
GlobeNewswire
·
April 14, 2025
PALO ALTO, Calif., April 14, 2025 (GLOBE NEWSWIRE) -- HP Inc. (NYSE: HPQ) today announced the pricing of its underwritten public offering of $1 billion aggregate principal amount of senior unsecured notes, consisting of $500 million aggregate principal …
NR7 Miner cloud mining adds 170,000 new users in a week through cloud computing power to mine Bitcoin
GlobeNewswire
·
April 14, 2025
London, UK, April 14, 2025 (GLOBE NEWSWIRE) -- This week, the cryptocurrency market has experienced a roller coaster ride. Amid the uncertainty of tariff policies, Bitcoin once fell to around $74,500, and then quickly rebounded to above $84,000 due to …
Applied Therapeutics Reports Fourth Quarter and Year-end 2024 Financial Results
GlobeNewswire
·
April 14, 2025
- Appointed John H. Johnson as Executive Chairman; Todd F. Baumgartner, MD, MPH as Chief Regulatory Officer; and Reena Thomas Colacot as Vice President and Head of Quality NEW YORK, April 14, 2025 (GLOBE NEWSWIRE) -- Applied Therapeutics, Inc. (Nasdaq: …
BioSyent to Attend Planet MicroCap Showcase
GlobeNewswire
·
April 14, 2025
MISSISSAUGA, Ontario, April 14, 2025 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, TSX Venture: RX) is pleased to announce that it will be attending the Planet MicroCap Showcase: VEGAS 2025 investor conference in Las Vegas, Nevada from April 22nd to April …
Bannix Acquisition Corp. Announces Monthly Extension to Complete its Initial Business Combination
GlobeNewswire
·
April 14, 2025
WILMINGTON, Del., April 14, 2025 (GLOBE NEWSWIRE) -- Bannix Acquisition Corp. (“Bannix”) announced today that its board of directors (the “Board”) has decided to extend the date by which Bannix must consummate an initial business combination (the “Deadline …
Update: NextNav Announces Date for First Quarter 2025 Earnings Call
GlobeNewswire
·
April 14, 2025
RESTON, Va., April 14, 2025 (GLOBE NEWSWIRE) -- NextNav (Nasdaq: NN), a leader in next generation positioning, navigation, timing (PNT) and 3D geolocation, today announced that it will release its financial results for the first quarter ended March 31, …
Cue Biopharma Announces Proposed Public Offering
GlobeNewswire
·
April 14, 2025
BOSTON, April 14, 2025 (GLOBE NEWSWIRE) -- Cue Biopharma, Inc. (Nasdaq: CUE), a clinical-stage biopharmaceutical company developing a novel class of therapeutic biologics to selectively engage and modulate disease-specific T cells for the treatment of …
Cue Biopharma to Host Business Update Call and Webcast
GlobeNewswire
·
April 14, 2025
BOSTON, April 14, 2025 (GLOBE NEWSWIRE) -- Cue Biopharma, Inc. (Nasdaq: CUE), a clinical-stage biopharmaceutical company developing a novel class of therapeutic biologics to selectively engage and modulate disease-specific T cells for the treatment of …
Boehringer Ingelheim and Cue Biopharma partner to develop next-generation treatment for autoimmune and inflammatory diseases
GlobeNewswire
·
April 14, 2025
Partnership bolsters Boehringer’s autoimmune and inflammatory disease pipeline portfolio aiming to tackle areas of high unmet patient need. The agreement focuses on further research and development of a novel, first-in-class bispecific compound for T cell …
Dyne Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
April 14, 2025
WALTHAM, Mass., April 14, 2025 (GLOBE NEWSWIRE) -- Dyne Therapeutics, Inc. (Nasdaq: DYN), a clinical-stage company focused on advancing life-transforming therapeutics for people living with genetically driven neuromuscular diseases, today announced that it …
ARB IOT Group Limited Secures Approximately USD53.0 Million Order for Supplying AI Servers
GlobeNewswire
·
April 14, 2025
Kuala Lumpur, Malaysia, April 14, 2025 (GLOBE NEWSWIRE) -- ARB IOT Group Limited (“ARB IOT” or the “Company”) (NASDAQ: ARBB) today announced that it has, through its indirect wholly owned subsidiary, ARB R1 Technology Sdn Bhd, successfully entered into a …
Voting Rights and Shares Capital of the Company
GlobeNewswire
·
April 14, 2025
In accordance with articles L.233-8 II of the French Commercial Code and 223-16 of the General Regulation of the French Financial Markets Authority (Autorité des Marchés Financiers) PARIS, April 14, 2025 (GLOBE NEWSWIRE) -- Market: Euronext Paris / Nasdaq …